Oncoprint profile of CYCS, VEGFA, IL6, UQCRC1, UQCRFS1, COX5B, ACKR3/CXCR7, and FYN indicated that these genes were either amplified or overexpressed in 4–25% of the ovarian cancer patients (Figure 4A). This evidence concerns the gene COX5B and ovarian cancer.